. | . |
Travis AFB hosts clinical research for NASA's newly developed medical technology by Senior Airman Christian Conrad Travis AFB CA (AFNS) Oct 27, 2020
NASA representatives presented new medical diagnostic technology, the E-Nose Breathalyzer, to members of David Grant USAF Medical Center Oct. 21, 2020, at Travis Air Force Base. The E-Nose Breathanalyzer, under development at NASA's Ames Research Center in Silicon Valley, will have the capability of analyzing compounds found within a person's breath to diagnose a battery of illnesses and abnormalities including respiratory illnesses, infectious diseases and cardiovascular conditions. As the science continues to be explored, the breath analyzer may one day be used to diagnose cancer. Travis AFB Airmen are hosting the NASA technology and collaborative research at the DGMC clinical investigation facility. "The technology is designed to make rapid measurements, in less than 5 minutes, at the point of care, in a way that is completely non-invasive. When fully realized, the NASA E-Nose will open a new realm of medical care to both the warfighter and potential space travelers," said Dr. David Loftus, NASA Ames Research Center medical officer and principal investigator of the Space Biosciences Research Branch. "The technology itself is handheld," Loftus said. "This makes it valuable not only to the U.S. Air Force during aeromedical evacuation, but also to NASA, as a tool for monitoring the health of astronauts far from medical centers on Earth. Human exploration of space, to the Moon and Mars, will require compact medical diagnostics technologies that can be ruggedized for field use. The Air Force and other branches of the military share this requirement." Loftus, who visited Travis AFB two years ago on a search for facilities that would best advance the capabilities of the E-Nose toward its eventual clinical application, cites the base's robust testing capabilities as the reason it was chosen. "We like to think of Travis (AFB) as the bridge between benchtop and bedside," Loftus said. "Its ability to perform the necessary tests needed to ensure the feasibility and practical use of this technology really formed the connective tissue that allowed it to go from an idea to a usable device, capable of improving the lives of countless people." The mission of improving lives is one that both NASA and DGMC have in common. This new technology not only has the potential to improve care for warfighters, but for the nation's civilian population as well, said Dr. Bradley Williams, 60th Medical Group clinical research administrator. "As with past technology that has been developed by the Air Force at DGMC, NASA medical research can improve civilian care throughout the country," Williams said. "The Air Force and NASA share the same altruistic medical research mission. Together, we seek to develop the future medical care which will be needed by the U.S. Space Force and which will also be very useful to the rest of the nation's hospitals." In his comments during the event, Loftus made sure to give praise to those who were chiefly responsible for the device's development. "Dr. Jing Li, the project lead, and Dr. Tore Straume, both at NASA Ames Research Center, are important members of the group, along with Dr. Matthew Coleman and Dr. Matthias Frank at Lawrence Livermore National Laboratory. This is very much a team effort." The future of the relationship between DGMC and NASA looks bright, with plans for future collaborative medical research between the two institutions currently in talks, particularly in the fields of nutritional medicine and blood analysis.
Three tissue engineering projects for ISS experiments awarded Kennedy Space Center FL (SPX) Oct 20, 2020 The Center for the Advancement of Science in Space (CASIS) and the National Science Foundation (NSF) announced three flight projects that were selected as part of a joint solicitation focused on leveraging the International Space Station (ISS) U.S. National Laboratory to further knowledge in the fields of tissue engineering and mechanobiology. Through this collaboration, CASIS, manager of the ISS National Lab, will facilitate hardware implementation, in-orbit access, and astronaut crew time on the ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |